POLYMED1,749.00

Poly Medicure Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersPFIZERRAINBOWONESOURCEKIMSJUBLPHARMAVIJAYAINDGNGRANULESMcap ₹17,728 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,375.81,669.81,875.31,997.4
Other Income58.789.1120.1111.4
Total Income1,434.51,759.01,995.32,108.8
Expenses
+ Cost of Materials Consumed464.8571.4599.4642.2
+ Purchases of Stock-in-Trade7.07.95.16.9
+ Changes in Inventories10.8-24.6-7.6-39.7
+ Employee Benefit Expense245.9301.5402.3457.1
+ Finance Costs11.312.018.321.8
+ Depreciation & Amortisation63.982.6115.5128.2
+ Other Expenses289.1360.8433.9469.7
Total Expenses1,092.81,311.61,566.81,686.1
EBITDA358.2452.8442.3461.4
EBIT294.3370.2326.8333.2
Profit
PBT before Exceptional Items341.7447.3428.6422.7
+ Exceptional Items0.00.0-6.8-6.8
Pretax Income341.7447.3421.8415.9
+ Current Tax77.095.7101.5107.6
+ Deferred Tax9.018.35.31.3
Tax Expense86.0114.0106.7108.9
+ Share of Associates & JVs2.55.25.75.9
Net Income258.3338.6320.7312.9
+ Net Income — Continuing Ops255.7333.4315.0307.0
+ Other Comprehensive Income-0.9-1.446.547.1
Total Comprehensive Income257.4337.2367.2360.1
Net Income to Common258.3338.6322.1315.1
Minority Interest0.00.0-1.4-2.2
Per Share
Basic EPS26.9234.1331.7931.09
Diluted EPS26.9034.1131.7531.06
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.446.547.1
+ Items NOT to be Reclassified to P&L-1.1-2.10.30.6
+ Tax on Items NOT to be Reclassified-0.50.10.1
+ Tax on Items NOT to be Reclassified — alt tag-0.3
+ Items to be Reclassified to P&L-0.00.246.346.7
Comprehensive Income — Owners of Parent-0.9337.2368.7291.3
Comprehensive Income — Non-controlling Interests0.00.0-1.4-2.1
Per Share — as-filed variants
Basic EPS — Continuing Operations26.9234.1331.7931.09
Diluted EPS — Continuing Operations26.9034.1131.7531.06
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit893.21,115.11,278.41,388.1
Gross Margin %64.9266.7868.1769.49
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)341.7447.3428.6422.7
− Exceptional Items (reconciliation)0.00.0-6.8-6.8
Net Income Adj (tax-effected)258.3338.6325.8317.9
EPS Adj26.9234.1332.2931.59
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value5.005.005.005.00
Paid Up Equity Capital48.050.750.750.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.